|
Type 2 diabetes
Citations 281-290 of 450 total displayed.
|
Past content
(since Jan 2001):
|
- Articles
Chronic Hyperglycemia Attenuates Coronary Collateral Development and Impairs Proliferative Properties of Myocardial Interstitial Fluid by Production of Angiostatin
- Dorothee Weihrauch, Nicole L. Lohr, Boris Mraovic, Lynda M. Ludwig, William M. Chilian, Paul S. Pagel, David C. Warltier, and Judy R. Kersten
Circulation published May 10, 2004, doi:10.1161/01.CIR.0000129225.67353.1F
[Abstract]
- Brief Rapid Communications
Angiotensin Type 1 Receptor Blockers Induce Peroxisome Proliferator–Activated Receptor- Activity
- Michael Schupp, Jürgen Janke, Ronald Clasen, Thomas Unger, and Ulrich Kintscher
Circulation 2004;109:2054-2057; published online before print as doi:10.1161/01.CIR.0000127955.36250.65
[Abstract]
[Full text]
- Clinical Investigations and Reports
Impact of Sirolimus-Eluting Stents on Outcome in Diabetic Patients: A SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) Substudy
- Issam Moussa, Martin B. Leon, Donald S. Baim, William W. O’Neill, Jeffery J. Popma, Maurice Buchbinder, Jay Midwall, Charles A. Simonton, Emily Keim, Patrick Wang, Richard E. Kuntz, and Jeffrey W. Moses
Circulation published May 3, 2004, doi:10.1161/01.CIR.0000129767.45513.71
[Abstract]
[Full text]
- Articles
Peroxisome Proliferator-Activated Receptor Ligand Bezafibrate for Prevention of Type 2 Diabetes Mellitus in Patients With Coronary Artery Disease
- Alexander Tenenbaum, Michael Motro, Enrique Z. Fisman, Ehud Schwammenthal, Yehuda Adler, Ilan Goldenberg, Jonathan Leor, Valentina Boyko, Lori Mandelzweig, and Solomon Behar
Circulation published May 3, 2004, doi:10.1161/01.CIR.0000126824.12785.B6
[Abstract]
- Review: Current Perspectives
Elevated Remnant-Like Particle Cholesterol Concentration: A Characteristic Feature of the Atherogenic Lipoprotein Phenotype
- T.B. Twickler, G.M. Dallinga-Thie, J.S. Cohn, and M.J. Chapman
Circulation 2004;109:1918-1925, doi:10.1161/01.CIR.0000125278.58527.F3
[Full text]
- Articles
Angiotensin Type 1 Receptor Blockers Induce Peroxisome Proliferator-Activated Receptor- Activity
- Michael Schupp, Jürgen Janke, Ronald Clasen, Thomas Unger, and Ulrich Kintscher
Circulation published April 26, 2004, doi:10.1161/01.CIR.0000127955.36250.65
[Abstract]
- Clinician Update
High-Density Lipoprotein and Cardiovascular Risk
- Peter P. Toth
Circulation 2004;109:1809-1812, doi:10.1161/01.CIR.0000126889.97626.B8
[Full text]
- Clinical Investigations and Reports
Association of Type 2 Diabetes With Cyclooxygenase-Mediated Inflammation and Oxidative Stress in an Elderly Population
- Johanna Helmersson, Bengt Vessby, Anders Larsson, and Samar Basu
Circulation 2004;109:1729-1734; published online before print as doi:10.1161/01.CIR.0000124718.99562.91
[Abstract]
[Full text]
- Clinical Investigations and Reports
Tight Glycemic Control in Diabetic Coronary Artery Bypass Graft Patients Improves Perioperative Outcomes and Decreases Recurrent Ischemic Events
- Harold L. Lazar, Stuart R. Chipkin, Carmel A. Fitzgerald, Yusheng Bao, Howard Cabral, and Carl S. Apstein
Circulation 2004;109:1497-1502; published online before print as doi:10.1161/01.CIR.0000121747.71054.79
[Abstract]
[Full text]
- Clinical Investigations and Reports
Clinical, Angiographic, and Procedural Predictors of Angiographic Restenosis After Sirolimus-Eluting Stent Implantation in Complex Patients: An Evaluation From the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) Study
- Pedro A. Lemos, Angela Hoye, Dick Goedhart, Chourmouzios A. Arampatzis, Francesco Saia, Willem J. van der Giessen, Eugene McFadden, Georgios Sianos, Pieter C. Smits, Sjoerd H. Hofma, Pim J. de Feyter, Ron T. van Domburg, and Patrick W. Serruys
Circulation 2004;109:1366-1370; published online before print as doi:10.1161/01.CIR.0000121358.26097.06
[Abstract]
[Full text]
|
|
